Nanjing Vishee Medical Technology Co Ltd
Nanjing Vishee Medical Technology Co., Ltd provides rehabilitation meditation products and solutions in China and internationally. The company offers MagNeuro, a transcranial magnetic stimulation (TMS) for use in anxiety disorders, movement disorders, and ADHD applications; MagNeuro ONE, a TMS therapy system with navigation for use in anxiety disorders applications; and MagBelle, a pelvic floor m… Read more
Nanjing Vishee Medical Technology Co Ltd (688580) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.026x
Based on the latest financial reports, Nanjing Vishee Medical Technology Co Ltd (688580) has a cash flow conversion efficiency ratio of 0.026x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥42.79 Million) by net assets (CN¥1.66 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Nanjing Vishee Medical Technology Co Ltd - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how Nanjing Vishee Medical Technology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Nanjing Vishee Medical Technology Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Nanjing Vishee Medical Technology Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Jiangsu Zeyu Intelligent Power Co.Ltd.
SHE:301179
|
N/A |
|
Jiangsu Tongda Power Technology Co Ltd
SHE:002576
|
0.007x |
|
ShaoYang Victor Hydraulics Co.Ltd
SHE:301079
|
N/A |
|
The Hackett Group Inc
NASDAQ:HCKT
|
0.280x |
|
One United Properties SA
RO:ONE
|
-0.010x |
|
Jiangsu Boamax Technologies Group Co Ltd
SHE:002514
|
0.095x |
|
Halfords Group plc
PINK:HLFDF
|
0.209x |
|
PHARMANUTRA S.P.A.
F:761
|
N/A |
Annual Cash Flow Conversion Efficiency for Nanjing Vishee Medical Technology Co Ltd (2013–2024)
The table below shows the annual cash flow conversion efficiency of Nanjing Vishee Medical Technology Co Ltd from 2013 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥1.63 Billion | CN¥118.29 Million | 0.073x | -11.90% |
| 2023-12-31 | CN¥1.63 Billion | CN¥134.20 Million | 0.082x | +46.34% |
| 2022-12-31 | CN¥1.53 Billion | CN¥86.17 Million | 0.056x | -45.08% |
| 2021-12-31 | CN¥1.53 Billion | CN¥157.37 Million | 0.103x | +19.93% |
| 2020-12-31 | CN¥1.41 Billion | CN¥120.76 Million | 0.086x | -84.58% |
| 2019-12-31 | CN¥254.86 Million | CN¥141.47 Million | 0.555x | +26.84% |
| 2018-12-31 | CN¥196.16 Million | CN¥85.84 Million | 0.438x | +28.26% |
| 2017-12-31 | CN¥153.42 Million | CN¥52.35 Million | 0.341x | +30.17% |
| 2016-12-31 | CN¥118.20 Million | CN¥30.98 Million | 0.262x | +10.44% |
| 2015-12-31 | CN¥106.25 Million | CN¥25.22 Million | 0.237x | -2.51% |
| 2014-12-31 | CN¥61.64 Million | CN¥15.01 Million | 0.243x | +14.83% |
| 2013-12-31 | CN¥38.81 Million | CN¥8.23 Million | 0.212x | -- |